4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-007281
Options or other derivatives
- PRESIDENT AND CEO acquired 1,199,331 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-04 | Grant or award · Employee Stock Option (right to buy) | +735,294 | 735,294 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-04 | Grant or award · Restricted Stock Units | +464,037 | 464,037 | D | ||
Loading xslF345X05/form4-03062025_100358.xml…